Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE

View Full Size 

Download

• Full Size JPEG, 1609x335, 110.2 KB
• Small JPEG, 480x100, 25.3 KB
• Preview JPEG, 144x30, 4.9 KB
• Thumbnail JPEG, 120x25, 3.5 KB